Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection  by van de Weg, Cornelia A.M. et al.
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Background:  Endothelial  cell dysfunction  is  believed  to  play  an  important  role  in  the pathogenesis  of
plasma  leakage  in  patients  with  acute  dengue  virus  (DENV)  infection.  Several  factors,  produced  by acti-
vated endothelial  cells,  have  been  associated  with  plasma  leakage  or severe  disease  in patients  with
infectious  diseases.
Objectives: The  aim  of  this  study  was  to  investigate  which  of these  markers  could  serve  as  a surrogate
marker  for the occurrence  of plasma  leakage  in patients  with  acute  DENV  infection.
Study design:  A  case-control  study  was performed  in  patients  with  acute  DENV  infection  in  Santos,  Brazil.
Plasma  leakage  was  detected  with  X-ray  and/or  ultrasound  examination  at admission.  Serum  levels  of
soluble  endoglin,  endothelin-1,  angiopoietin-2,  VEGF,  soluble  VEGFR-2,  MMP-2,  MMP-9,  TIMP-1  and
TIMP-2  were  determined  using  commercially  available  ELISAs.
Results:  Increased  levels  of  angiopoietin-2,  endothelin-1  and  MMP-2  and  decreased  levels  of  soluble
VEGFR-2  were  signiﬁcantly  associated  with  the  occurrence  of plasma  leakage.  An  unsupervised  clus-
ter  analysis  conﬁrmed  that  angiopoietin-2  and  soluble  VEGFR-2  were  strongly  associated  with  clinical
apparent  vascular  leakage.
Conclusion:  Angiopoietin-2  and  soluble  VEGFR-2  can  serve  as surrogate  markers  for  the  occurrence  of
plasma  leakage  in  patients  with  acute  DENV  infection.Abbreviations: DENV, dengue virus; VEGF, vascular endothelial growth factor;
MP, matrix metalloproteinase; TIMP, tissue inhibitor of matrix metallopro-
einases; Ang, angiopoietin; Eng, endoglin; ET-1, endothelin-1; RT-PCR, real time
CR; Chi, Chi-squared test; MWU, Mann–Whitney U test; F, Fisher’s exact test; MV,
issing value; WS−, non-severe dengue without warning signs; WS+, non-severe
engue with warning signs; HC, healthy control.
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1. Background
Dengue virus (DENV) is a ﬂavivirus, which is transmitted by the
bite of a mosquito. A recent study showed that 390 million persons
are infected with DENV each year, of which 96 million develop clin-
ical symptoms [1]. A hallmark of dengue disease is an increase in
vascular permeability, presented as pleural effusion and/or ascitis.
In severe cases, extensive plasma leakage may  lead to the develop-
ment of hypotension and shock [2].
Endothelial cells play a crucial role in the development of plasma
leakage during DENV infection. DENV can infect endothelial cells
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Table  1
Characteristics of patients with and without plasma leakage.
No plasma leakage
(N = 56)
Plasma leakage (N = 49) Healthy controls
(N = 15)
Signiﬁcance
Sex 59% male (N = 33) 63% male (N = 31) 60% male (N = 9) p = 0.9 (Chi)
Age* 21 (11–45) 12 (8–29) 25 (24–28) p = 0.001 (KW)
Day  of fever* 5 (4–6) 5 (4–7) MV  = 1 NA p = 0.9 (MWU)
2009  WHO  dengue
case classiﬁcation
64% (N = 36) WS−
34% (N = 19) WS+
2% (N = 1) Severe
100% (N = 49) WS+  NA p < 0.0001 (Chi)
Admission 52% (N = 29) MV=2 96% (N = 47) MV=1 NA p < 0.0001 (F)
Type  plasma leakage – Ascites: 29% (N = 14)
Pleural: 16% (N = 8)
Pleural and
pericardium: 55%
(N  = 27)
NA
Haemorrhagic
manifestations
30% (N = 17) 47% (N = 23) NA p = 0.1 (F)
Type  haemorrhagic
manifestation
70% (N = 39) No
25% (N = 14) Minor
mucosal
5% (N = 3) Petechiae
53% (N = 26) No
31% (N = 15) Minor
mucosal
16% (N = 8) Petechiae
NA
Platelet count* 122.500
(57.250–166.500)
MV = 2
42.000
(33.000–73.000)
NA p < 0.0001 (MWU)
Viremic 73% (N = 41) 59% (N = 29) NA p = 0.2 (F)
Viral  copy number in
viremic patients
(copies/ml)*
198 (122–950) 126 (100–256) NA p = 0.01 (MWU)
IgG  avidity* 21% (N = 12) Not
detectable
2% (N = 1) Primary
77% (N = 43) Secondary
2% (N = 1) Not
detectable
98% (N = 48) Secondary
NA p = 0.006 (Chi)
Abbreviations: Statistical test used is the: Chi = Chi-squared test; KW = Kruskal Wallis test; MWU  = Mann–Whitney U test; F = Fisher’s exact test. MV = missing value. WS− = non-
severe  dengue without warning signs. WS+  = non-severe dengue with warning signs. NA = not applicable.
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n vitro, but whether this also occurs in vivo, is still a matter
f debate [3,4]. Moreover, it is not clear whether DENV causes
ascular permeability by direct infection of endothelial cells or
hrough the release of vasoactive agents by infected monocytes and
acrophages, which are the primary target cells of DENV infection
4]. In vitro, direct infection of endothelial cells did not lead to an
ncrease in permeability, while co-incubation of endothelial cells
ith mononuclear cells or the supernatant from DENV-infected
onocytic cells did result in an increase [5,6]. This suggests that
echanisms other than direct infection may  activate endothelial
ells, resulting in an increase in vascular permeability. It is believed
hat uncontrolled endothelial activation and subsequent dysfunc-
ion contributes to the severity of dengue (reviewed in [7]).
Vascular endothelial growth factor (VEGF), initially identiﬁed
s vascular permeability factor, promotes the growth, prolifera-
ion and migration of endothelial cells. VEGF is increased in DENV
nfected patients with plasma leakage, especially around the time of
efervescence [8,9]. VEGF can be bound to sVEGFR-1 and sVEGFR-
, which are expressed predominantly on endothelial cells [10].
evels of sVEGFR-1 were increased in patients with severe dengue,
ontrasting with decreased levels of sVEGFR-2 [8].
Matrix metalloproteinases (MMPs) are proteolytic enzymes that
an cleave proteins of the extracellular matrix [11]. The activity of
hese enzymes is regulated by tissue inhibitors of matrix metallo-
roteinases (TIMPs). Endothelial cells produce MMP-2 and MMP-9
nd also TIMP-1 and TIMP-2 [12]. Increased levels of MMP-9 were
etected in patients with severe DF compared to mild DF [13]. In
he same study, no signiﬁcant differences were detected in MMP-2
evels between dengue fever patients and healthy controls.
Angiopoietin-1 (Ang-1) is produced by perivascular cells and
as a stabilizing effect on the vascular barrier [14]. Angiopoietin-2(Ang-2) is synthesized by endothelial cells and is a potent inducer
of vascular permeability by counteracting the barrier stabilizing
effects of Ang-1 [15]. Decreased levels of Ang-1 and increased levels
of Ang-2 were correlated with the occurrence of plasma leakage
in DENV infected patients, suggesting that an imbalance between
these two  proteins may  be involved in endothelial dysfunction [16].
Activated endothelial cells produce a number of other pro-
teins, including soluble endoglin (sEng) and endothelin-1 (ET-1).
Upon inﬂammation, Eng is cleaved by MMPs and released in the
circulation as sEng. sEng binds to TGF-1 and abrogates its anti-
inﬂammatory effects. Levels of sEng were increased in children
with severe malaria [17]. ET-1 is produced by endothelial cells
and is a potent vasoconstrictor and has inotropic, chemotactic and
mitogenic properties [18]. Increased levels have been detected in
patients with sepsis and malaria [19,20].
2. Objectives
The aim of this study was  to investigate which of the following
markers sEng, ET-1, MMP-2, MMP-9, TIMP-1, TIMP-2, Ang-2, VEGF
and sVEGFR-2, all produced by activated endothelial cells, could
serve as a surrogate marker for the increase in vascular permeabil-
ity during DENV infection.
3. Study design
3.1. Clinical cohortThis cohort has been previously described [21–24]. Brieﬂy,
during the 2010 outbreak, samples were collected from patients
with clinical suspected dengue presenting at the Ana Costa
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Fig. 1. The association of endothelial markers with the occurrence of plasma leakage. Levels of Ang-2 (A), MMP-2 (C) and ET-1 (D) were signiﬁcantly increased and levels
of  sVEGFR-2 (B) were signiﬁcantly decreased in patients with plasma leakage compared to patients with no plasma leakage. Levels of Ang-2 (A), TIMP-1 (E), TIMP-2 (F),
M o hea
A ng val
s
H
w
I
t
K
S
c
o
w
a
t
d
b
3
D
c
a
w
a
3
T
e
GMP-9  (G) and VEGF (H) were signiﬁcantly elevated in dengue patients compared t
bbreviations:  No, no plasma leakage; PL, plasma leakage; HC, healthy control. Missi
Eng:  no missing values; VEGF: No (N = 4), PL (N = 5).
ospital, Santos, State of São Paulo. Patients were diagnosed
ith DENV infection by detection of DENV NS1 antigen and/or
gM-speciﬁc antibodies using a commercially available rapid
est (Dengue duo test bioeasy, Standard Diagnostic Inc., 575-34,
orea) or by detection of DENV RNA by real time PCR (RT-PCR).
erum samples were drawn and stored at −80 ◦C. Patients were
lassiﬁed according to the 2009 WHO  classiﬁcation [25,26] and the
ccurrence of plasma leakage. The occurrence of plasma leakage
as detected by ultrasound or X-ray examination performed upon
 clinical suspicion for plasma leakage, such as hemoconcentra-
ion, profound thrombocytopenia, tachycardia, hypotension or
ehydration. Healthy volunteers with a similar socio-economic
ackground were used as the reference group.
.2. IgG avidity ELISA
The IgG avidity test was  used to determine primary or secondary
ENV infection [27]. Samples with low avidity IgG antibodies were
lassiﬁed as primary DENV infection, whereas samples with high
vidity IgG antibodies were classiﬁed as secondary. Samples in
hich IgG antibodies were not detected could not be classiﬁed,
lthough the majority was probably primary DENV infection.
.3. Determination of viral loadViral load was determined by an “in-house” RT-PCR method.
his method has been previously described in detail [24]. RNA was
xtracted from plasma using the Qiagen Viral RNA kit (Qiagen,
ermany). The RT-PCR was conducted in duplicate. SuperScript IIIlthy controls. Levels of sEng (I) were not signiﬁcantly different in any of the groups.
ues: Ang-2, sVEGFR-2: PL (N = 2); MMP-2, ET-1, MMP-9: PL (N = 1); TIMP-1, TIMP-2,
Platinum SYBR Green One-Step qRT-PCR kit with ROX (Invitrogen,
Inc., EUA) was  used. Primers covering all four DENV serotypes were
used of which the sequences have been published [28].
3.4. Endothelial cell markers
Levels of sEng, ET-1, MMP-2, MMP-9, TIMP-1, TIMP-2, Ang-2,
VEGF and sVEGFR-2 were measured using commercially available
ELISA kits (‘Quantikine’, R&D systems, USA). The sensitivity limits
in the diluted samples were sEng (0.03 ng/ml), ET-1 (0.207 pg/ml),
MMP-2 (0.082 ng/ml), MMP-9 (0.156 ng/ml), TIMP-1 (0.08 ng/ml),
TIMP-2 (0.064 ng/ml), Ang-2 (21.3 pg/ml), VEGF (9 pg/ml) and
sVEGFR-2 (11.4 pg/ml). The assays were performed according to the
manufacturer’s instructions. Every sample was run in duplicates.
Repetitive freeze–thaw cycles were avoided.
3.5. Cluster analysis
The cluster analysis procedure was adapted from van den
Ham et al. [29]. Brieﬂy, permeability marker values were log-
transformed and subjected to hierarchical correlation clustering
(i.e., with distance measure 1 – pearson’s pairwise correlation
value) using Ward’s method that minimizes within-cluster vari-
ance. Both patients and permeability markers were clustered to
obtain a heatmap. VEGF was excluded and one patient as well,
because too many values were missing. Cluster analysis was per-
formed in R 2.15 (R Development Core Team [R Foundation for
Statistical Computing], 2012, www.r-project.org). R scripts used to
construct the trees and heatmaps are available upon request.
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Fig. 2. The association of endothelial markers with the 2009 WHO  dengue case classiﬁcation. Levels of Ang-2 (A) and ET-1 (D) were signiﬁcantly increased and levels of
sVEGFR-2 (B) were signiﬁcantly decreased in patients with WS+  compared to patients with WS− dengue. Levels of Ang-2 (A), TIMP-1 (E), MMP-9 (G)  and VEGF (H) were
signiﬁcantly elevated in dengue patients compared to healthy controls. Levels of MMP-2 (C) and TIMP-2 (F) were signiﬁcantly increased in WS+  compared to healthy controls.
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S+  (N = 7).
.6. Statistical analysis
The Kruskal Wallis H and the Mann Whitney U test were
sed for comparisons of more than two or between two  groups,
espectively. Correlations were determined using the Spearman’s
orrelation coefﬁcient. The Chi-squared test was used to calculate
hether the distribution was signiﬁcantly different between more
han two groups and/or conditions and the Fisher’s exact test in case
f two groups/conditions. P values ≤ 0.05 were considered signiﬁ-
ant. Using the Bonferroni correction, a p-value cut-off of ≤0.02 for
ndothelial cell marker analyses was applied.
. Results
For this study, 105 out of 811 patients with laboratory con-
rmed acute DENV infection were selected based on the absence
r presence of plasma leakage and the availability of sample and
linical data. Forty-nine patients with plasma leakage and ﬁfty-six
ithout were included and they were stratiﬁed based on gender
nd day after the onset of fever. Patients with severe co-morbidity
ere excluded from this analysis. The clinical characteristics of the
atients are depicted in Table 1.Patients with plasma leakage were signiﬁcantly younger
p = 0.001), had signiﬁcantly lower levels of platelets (p < 0.0001)
nd a lower viral load (p = 0.01). Patients with plasma leakage
ere also less often viraemic, although this difference was  not non-severe dengue without warning signs; WS+, non-severe dengue with warning
MP-9: WS+  (N = 1); TIMP-1, TIMP-2, sEng: no missing values; VEGF: WS− (N = 2),
signiﬁcant. The IgG avidity test indicated that 98% of patients with
plasma leakage suffered from a secondary DENV infection. Of the
patients without plasma leakage, 21% had undetectable IgG anti-
bodies, suggesting that these patients presented with their ﬁrst
DENV episode. When patients were classiﬁed according to the 2009
WHO  classiﬁcation 69% from the WS− and 96% from the WS+
patients suffered from a secondary DENV infection.
To determine the association of endothelial cell markers with
the occurrence of plasma leakage, we  have measured the levels
of nine endothelial cell markers in the serum of DENV infected
patients and healthy controls. Levels of Ang-2, MMP-2 and ET-1
were signiﬁcantly increased and levels of sVEGFR-2 signiﬁcantly
decreased in patients with plasma leakage compared to patients
without plasma leakage (Fig. 1). The other markers, TIMP-1, TIMP-
2, MMP-9 and VEGF, were signiﬁcantly elevated in DENV infected
patients compared to healthy controls. Levels of sEng were not sig-
niﬁcantly different in any of the groups. The expression of Ang-2,
MMP-2, ET-1 and sVEGFR-2 was  only associated with the occur-
rence, but not with the type of plasma leakage (data not shown).
When patients were classiﬁed according to the 2009 WHO
dengue case classiﬁcation, levels of Ang-2 and ET-1 were also sig-
niﬁcantly elevated and levels of sVEGFR-2 signiﬁcantly decreased
in patients with WS+  compared to WS− dengue (Fig. 2).To investigate whether time after the onset of disease had an
impact on the expression of these nine markers, patients were
divided into three groups consisting of 2–3 days, 4–6 days and
≥7 days after onset of symptoms (Supplementary Fig. 1). There
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Fig. 3. Heatmap of the cluster analysis. A cluster analysis was performed with eight
endothelial markers, which resulted in a dendrogram indicated on the left of the
heatmap. Every horizontal line indicates one patient. The vertical bar on the left
of  the heatmap indicates the occurrence of plasma leakage in the patient. Cluster32 C.A.M. van de Weg  et al. / Journal
ere no signiﬁcant differences between the groups, suggesting that
ime after the onset of disease, independent from the occurrence
f plasma leakage, did not have a major impact on the expression
f these markers. Moreover, the Spearman’s correlation coefﬁcient
as also not signiﬁcant when the endothelial markers were directly
orrelated with the day after the onset of disease (data not shown).
The cluster analysis groups patients based on similarities in the
xpression of the determined markers (Fig. 3). In the resulting
eatmap, a dendrogram shows the similarity between the sub-
ects (left side of Fig. 3), where subjects in the same branch are
ore similar to each other than to subjects in other branches.
he subject dendrogram was divided into three main clusters
f which cluster A contained the largest proportion of DENV
nfected patients with plasma leakage and cluster B contained the
argest proportion of healthy controls (Table 2). Levels of sVEGFR-
 were clearly decreased and levels of Ang-2 increased in cluster
. Plasma leakage occurred signiﬁcantly more often in cluster A
han the other clusters (Chi-squared test, p < 0.0001). Levels of
MP-9 were increased in cluster C compared to the other clus-
ers.
The Spearman’s correlation coefﬁcient was used to correlate
he endothelial permeability markers with the platelet count and
ith each other. Ang-2 and sVEGFR-2 correlated strongly with
he platelet count (Ang-2:  = −0.63 (p < 0.0001), sVEGFR-2  = 0.74
p < 0.0001)) (Fig. 4A and B). Ang-2 and sVEGFR-2 also correlated
trongly with each other ( = −0.52 (p < 0.0001)) (Fig. 4C). More-
ver, a strong correlation was found between MMP-2 and TIMP-2
 = 0.60 (p < 0.0001)) (Fig. 4D). Interestingly, TIMP-2 has been
escribed to play a central role in modulating MMP-2 activity [30].
. Discussion
In this study, we have shown increased levels of Ang-2, MMP-2
nd ET-1 and decreased levels of sVEGFR-2 in patients with plasma
eakage. Moreover, cluster analysis conﬁrmed that increased
xpression of Ang-2 and decreased expression of sVEGFR-2 was
trongly associated with plasma leakage.
Patients with plasma leakage were signiﬁcantly younger than
atients without plasma leakage, which is in line with epidemiolog-
cal studies that have shown higher frequencies of plasma leakage
nd a propensity to develop dengue shock syndrome in children rel-
tive to adults [31–33]. It has been hypothesized that the capillaries
n growing children are more fragile and more sensitive to vasoac-
ive agents than the capillaries of adults [34].
In this study, patients were most frequently included on day
 after the onset of fever. It has been shown that DENV infected
atients are viraemic for ﬁve days on average [35]. Moreover,
atients with secondary DENV infection showed higher viral titres,
ut a shorter duration of their viraemia than patients with primary
ENV infection [35]. This may  explain why patients with plasma
eakage in our study had a lower viral load and were more often
xperiencing a secondary infection compared to patients without
lasma leakage.
This is the ﬁrst time that increased levels of ET-1 have been
etected in DENV infected patients with plasma leakage. ET-1 was
rst isolated from porcine aortic endothelial cells and is known
o be a potent inducer of vasoconstriction [18]. In patients with
eptic shock, elevated levels of ET-1 were associated with disease
everity and correlated signiﬁcantly with a lower cardiac index,
ost probably due to suppression of the cardiac function by ET-1
20]. Interestingly, a low cardiac index was also reported in patients
ith dengue shock syndrome [36].
MMPs can lyse the subendothelial basement membrane and
ould therefore contribute to the development of hyperperme-
bility. MMP-2 was signiﬁcantly elevated in patients with plasmaA  had the highest proportion of patients with plasma leakage. Cluster B contained
the majority of the healthy controls. Cluster C consisted of mainly DENV infected
patients and had a lower proportion of patients with plasma leakage than cluster A.
leakage compared to patients without plasma leakage, while MMP-
9 was  signiﬁcantly elevated in DENV infected patients compared
to healthy controls. It has been shown that DENV infection of
microvascular endothelial cells induced secretion of MMP-2 more
strongly than secretion of MMP-9 [37]. In contrast, DENV infected
dendritic cells secreted higher levels of MMP-9 than MMP-2 [38].
The association between MMP-2 (but not MMP-9) and the occur-
rence of plasma leakage suggests that endothelial cell activation
plays an important role in the development of vascular leakage.
No signiﬁcant differences in VEGF levels in patients with and
without plasma leakage were detected. Some studies have reported
increased levels of plasma VEGF in severe versus uncomplicated
dengue [8,9,39], while others did not detect any differences in
levels between severity groups [40,41]. Both in the supervised clin-
ical classiﬁcation and in the unsupervised cluster analysis, Ang-2
and sVEGFR-2 were strongly associated with the occurrence of
plasma leakage, which is in line with other clinical studies [8,16].
In vitro studies also showed that DENV infection of endothelial
cells resulted in decreased levels of sVEGFR-2 and increased Ang-
2 expression [8,42]. Ang-2 is synthesized by endothelial cells and
quickly released in the circulation upon activation [43]. Ang-1
and Ang-2 are antagonistic ligands of the Tie-2 receptor, a vascu-
lar speciﬁc tyrosine kinase receptor. Ang-1/Tie-2 signalling brings
the endothelium in a quiescent state, while Ang-2/Tie-2 signalling
results in endothelial detachment [15]. In line with this study,
increased levels of circulating endothelial cells have been detected
in patients with DHF [44]. Another study showed that Ang-2 stim-
ulation of endothelial cells resulted in an increase in vascular
permeability due to downregulation of proteins in the adherent and
tight junctions between the cells [42]. Interestingly, VEGF-sVEGFR-
2-signalling also affects the adherens junction, because it causes
endocytosis of VE-cadherin in the endothelial cell [45].
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Table  2
Characteristics of the three clusters in the cluster analysis.
Cluster A (N = 60) Cluster B (N = 32) Cluster C (N = 27) Statistics
Age* 15 (11–46) 11 (9–17) 18 (9–33) p = 0.6 (KW)
Gender 65% (N = 39) male 53% (N = 17) male 63% (N = 17) male p = 0.53 (Chi)
2009  WHO  dengue
case classiﬁcation
20% (N = 12) WS−
75% (N = 45) WS+
2% (N = 1) Severe
3% (N = 2) HC
31% (N = 10) WS−
34% (N = 11) WS+
34% (N = 11) HC
52% (N = 14) WS−
44% (N = 12) WS+
4% (N = 1) HC
p < 0.0001 (Chi)
Plasma leakage 62% (N = 37) 19% (N = 6) 22% (N = 6) p < 0.0001 (Chi)
Haemorrhage 42% (N = 25) 13% (N = 4) 41% (N = 11) p < 0.0001 (Chi)
Angiopoietin-2*
(pg/ml)
20.751
(14.851–27.775)
MV = 2
8.806 (6.463–12.524)
MV = 1
8.210 (6.926–9.703)
MV  = 1
NA
Endoglin* (ng/ml) 13.5 (11.5–15.2) 13.4 (10.2–16.0) 14.1 (12.2–17.1) NA
Endothelin-1* (pg/ml) 10.4 (8.2–12.8) MV  = 1 8.2 (6.8–11.4) 7.8 (5.5–9.6) NA
MMP-2* (ng/ml) 756 (645–851) MV  = 1 685 (587–779) 589 (539–696) NA
MMP-9* (ng/ml) 470 (297–648) MV  = 1 170 (115–253) MV = 1 982 (721–1511) MV = 1 NA
sVEGFR-2* (pg/ml) 7.893 (6.394–10.168)
MV  = 3
10.769 (9.525–18.341) 18.277
(13.342–25.234)
MV = 1
NA
TIMP-1* (ng/ml) 874 (641–1137) 529 (397–986) MV  = 1 861 (625–1199) MV = 1 NA
TIMP-2* (ng/ml) 302 (233–354) 291 (260–347) 275 (207–304) NA
Abbreviations: MV  = missing value (due to failure in the assay, e.g. variation in duplo too large). KW = Kruskal Wallis test. Chi = Chi-squared test. WS− = non-severe dengue
w  contr
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(ithout warning signs. WS+  = non-severe dengue with warning signs. HC = healthy
etermine the formation of the clusters.
* Values are in median (interquartile range).
Because of the cross-sectional study design we  could not draw
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